'The Maze Runner' Production Has Been Halted

by Amy Roberts

As was reported in March, whilst filming the third installment of The Maze Runner trilogy, Dylan O'Brien was injured on-set, temporarily shutting down production of the film whilst he recovered. Though we were all rooting for a swift, speedy recovery from his injuries, it now sounds as though O'Brien's injuries might be more serious than they were originally reported. According to Vulture, Maze Runner: The Death Cure's production was reportedly stopped indefinitely to give O'Brien more recovery time.

According to sources via The Hollywood Reporter, "cast and crew have been sent home, and a new start date will depend on O'Brien's recovery." Additionally, O'Brien's publicist is quoted as saying that "his injuries are very serious and he needs more time to recover."

A statement from 20th Century Fox, The Maze Runner's studio, has also confirmed that O'Brien requires more time to recover from injuries:

The resumption of principal photography on Maze Runner: The Death Cure has been further delayed to allow Dylan O’Brien more time to fully recover from his injuries ... We wish Dylan a speedy recovery and look forward to restarting production as soon as possible.

Maze Runner: The Death Cure was originally scheduled for release on February 17, 2017 — though it seems likely that this dramatic setback could well impact on that timeline and postpone release 'til a later date. The film, which is the final chapter of the Maze Runner trilogy, follows O'Brien's character as he seeks out a cure for a deadly disease known only as the "Flare," and is directed by Wes Ball. Ball's original statements regarding O'Brien's injuries, released in March, still remain strong and touching:

Well, it’s been a whirlwind of emotions these past few days. I’ve been overwhelmed with feelings of anger and sadness and guilt. But, ultimately I find myself left with just a deep love and respect for Dylan. He is one tough cookie.

Here's wishing O'Brien good health and a speedy recovery.